SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-021536
Filing Date
2020-05-06
Accepted
2020-05-06 07:17:53
Documents
105
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q hznp-10q_20200331.htm   iXBRL 10-Q 3490286
2 EX-4.5 ex45.htm EX-4.5 12238
3 EX-4.6 ex46.htm EX-4.6 13626
4 EX-31.1 hznp-ex311_654.htm EX-31.1 16067
5 EX-31.2 hznp-ex312_653.htm EX-31.2 15829
6 EX-32.1 hznp-ex321_652.htm EX-32.1 8953
7 EX-32.2 hznp-ex322_651.htm EX-32.2 8983
  Complete submission text file 0001564590-20-021536.txt   13255278

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA hznp-20200331.xsd EX-101.SCH 98745
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hznp-20200331_cal.xml EX-101.CAL 74328
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hznp-20200331_def.xml EX-101.DEF 386049
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE hznp-20200331_lab.xml EX-101.LAB 666052
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hznp-20200331_pre.xml EX-101.PRE 580697
57 EXTRACTED XBRL INSTANCE DOCUMENT hznp-10q_20200331_htm.xml XML 2568237
Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4
Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100
Horizon Therapeutics Public Ltd Co (Filer) CIK: 0001492426 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35238 | Film No.: 20851126
SIC: 2834 Pharmaceutical Preparations